Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5862766 | 0.79 | CA2 (0.33) | CA2CES2CES1 | |
| SCHEMBL5861758 | 0.79 | — | — | |
| SCHEMBL6408848 | 0.79 | CA2 (0.33) | CA2CES2CES1 | |
| SCHEMBL26089480 | 0.79 | ALDH1A1 (0.33) | CA2CES2CES1 | |
| SCHEMBL27892503 | 0.76 | CA2 (0.41) | CA2CES2CES1 | |
| SCHEMBL344 | 0.76 | CA2 (0.41) | CA2CES2CES1 | |
| Benzene SCHEMBL28159586 | 0.74 | CES1 (0.46) | CA2CES2CES1 | |
| SCHEMBL6906187 | 0.73 | CA2 (0.30) | CA2CES2 | |
| SCHEMBL3583074 | 0.73 | CES2 (0.34) | CA2CES2 | |
| SCHEMBL20377897 | 0.73 | CA2 (0.30) | CA2CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6774266-B2 | Process for producing 1,1,1-trifluoroacetone | CENTRAL GLASS COMPANY, LIMITED (JP) | 2004-08-10 | — | — | US | disclosed |
| US-20030114713-A1 | Process for producing 1,1,1- trifluoroacetone | CENTRAL GLASS COMPANY, LIMITED (JP) | 2003-06-19 | — | — | US | disclosed |
| US-4060532-A | Halogenated dioxolane tranquilizers | ICI UNITED STATES INC. (US) | 1977-11-29 | — | — | US | disclosed |
| US-3996376-A | Halogenated dioxolane tranquilizers | ICI UNITED STATES INC. (US) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114713-A1 | Process for producing 1,1,1- trifluoroacetone | TCOF1, RIF1, TALDO1 | CA2 239/4885CES2 1144/4885CES1 510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.